AAAAAA

   
Results: 1-9 |
Results: 9
MURINE IL-2 RECEPTOR-BETA CHAIN BLOCKADE IMPROVES HUMAN-LEUKOCYTE ENGRAFTMENT IN SCID MICE
Authors: TOURNOY KG DEPRAETERE S MEULEMAN P LEROUXROELS G PAUWELS RA
Citation: Kg. Tournoy et al., MURINE IL-2 RECEPTOR-BETA CHAIN BLOCKADE IMPROVES HUMAN-LEUKOCYTE ENGRAFTMENT IN SCID MICE, European Journal of Immunology, 28(10), 1998, pp. 3221-3230
ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - EVOLUTION OF ANTIBODY-LEVELS AFTER INTERFERON THERAPY
Authors: DEPRAETERE S VANKERSCHAVER E ELEWAUT A BROUWER J NIESTERS B SCHALM S MAERTENS G LEROUXROELS G
Citation: S. Depraetere et al., ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - EVOLUTION OF ANTIBODY-LEVELS AFTER INTERFERON THERAPY, Hepatology, 26(4), 1997, pp. 338-338
ANTIBODIES TO E1 AND E2 IN CHRONIC HCV PATIENTS WITH A LONG-TERM RESPONSE TO INTERFERON THERAPY
Authors: DEPRAETERE S VANKERSCHAVER E VANVLIERBERGHE H ELEWAUT A DEPLA E MAERTENS G LEROUXROELS G
Citation: S. Depraetere et al., ANTIBODIES TO E1 AND E2 IN CHRONIC HCV PATIENTS WITH A LONG-TERM RESPONSE TO INTERFERON THERAPY, Hepatology, 26(4), 1997, pp. 717-717
ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - CORRELATION WITH RESPONSE TO INTERFERON THERAPY
Authors: DEPRAETERE S VANKERSCHAVER E ELEWAUT A BROUWER J NIESTERS B SCHALM S MAERTENS G LEROUXROELS G
Citation: S. Depraetere et al., ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - CORRELATION WITH RESPONSE TO INTERFERON THERAPY, Hepatology, 26(4), 1997, pp. 718-718
PREVALENCE OF GBV-C HGV AND NEW HCV MARKERS IN HEALTHY, VOLUNTARY BLOOD-DONORS WITH ELEVATED ALT LEVELS OF UNKNOWN ORIGIN/
Authors: ROOBROUCK A DEPRAETERE S COUVENT S VANKERSCHAVER E VANDURME H VANDEKERCKHOVE B MAERTENS G DEKEYSER F STOOPS E ZREIN M LEROUXROELS G
Citation: A. Roobrouck et al., PREVALENCE OF GBV-C HGV AND NEW HCV MARKERS IN HEALTHY, VOLUNTARY BLOOD-DONORS WITH ELEVATED ALT LEVELS OF UNKNOWN ORIGIN/, Hepatology, 26(4), 1997, pp. 792-792
PREVALENCE OF GBV-C HGV AND HCV IN 4 HEMODIALYSIS UNITS IN FLANDERS (BELGIUM)/
Authors: ROOBROUCK A DEPRAETERE S COUVENT S VANKERSCHAVER E MAERTENS G LEROUXROELS G
Citation: A. Roobrouck et al., PREVALENCE OF GBV-C HGV AND HCV IN 4 HEMODIALYSIS UNITS IN FLANDERS (BELGIUM)/, Hepatology, 26(4), 1997, pp. 1850-1850
POLAR AGENTS WITH DIFFERENTIATION-INDUCING CAPACITY POTENTIATE TUMOR NECROSIS FACTOR-MEDIATED CYTOTOXICITY IN HUMAN MYELOID CELL-LINES
Authors: DEPRAETERE S VANHAESEBROECK B FIERS W WILLEMS J JONIAU M
Citation: S. Depraetere et al., POLAR AGENTS WITH DIFFERENTIATION-INDUCING CAPACITY POTENTIATE TUMOR NECROSIS FACTOR-MEDIATED CYTOTOXICITY IN HUMAN MYELOID CELL-LINES, Journal of leukocyte biology, 57(1), 1995, pp. 141-151
POTENTIATION OF TUMOR NECROSIS FACTOR-MEDIATED CYTOTOXICITY ON HUMAN MYELOID CELL-LINES - EFFECTS OF INTERFERONS VERSUS DIMETHYLSULFOXIDE
Authors: DEPRAETERE S JONIAU M
Citation: S. Depraetere et M. Joniau, POTENTIATION OF TUMOR NECROSIS FACTOR-MEDIATED CYTOTOXICITY ON HUMAN MYELOID CELL-LINES - EFFECTS OF INTERFERONS VERSUS DIMETHYLSULFOXIDE, Leukemia research, 19(11), 1995, pp. 803-809
POLAR AGENTS WITH DIFFERENTIATION-INDUCING CAPACITY PRIME MYELOMONOCYTIC CELL-LINES TO LIPOPOLYSACCHARIDE-INDUCED CYTOLYSIS - THE ROLE OF ENDOGENOUS TUMOR-NECROSIS-FACTOR
Authors: DEPRAETERE S JONIAU M
Citation: S. Depraetere et M. Joniau, POLAR AGENTS WITH DIFFERENTIATION-INDUCING CAPACITY PRIME MYELOMONOCYTIC CELL-LINES TO LIPOPOLYSACCHARIDE-INDUCED CYTOLYSIS - THE ROLE OF ENDOGENOUS TUMOR-NECROSIS-FACTOR, Leukemia, 8(11), 1994, pp. 1951-1959
Risultati: 1-9 |